title: Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure.
authors.forename: M
authors.initials: M
authors.lastname: Wutte
authors.forename: M
authors.initials: M
authors.lastname: Hülsmann
authors.forename: R
authors.initials: R
authors.lastname: Berger
authors.forename: A
authors.initials: A
authors.lastname: Siegel
authors.forename: B
authors.initials: B
authors.lastname: Stanek
authors.forename: R
authors.initials: R
authors.lastname: Pacher
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage*; D003404:Creatinine / Q000097:blood; D004280:Dobutamine / Q000008:administration & dosage; D004298:Dopamine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects* / Q000502:physiology; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000098:blood supply*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D004280:Dobutamine; D003404:Creatinine; D000527:Alprostadil; D004298:Dopamine